Key result
Daily hemofiltration lacks quantitative outcome data for severe NYHA class IV heart failure.
Observational
No quantitative data to guide daily hemofiltration in severe HF; leaves open its role pending controlled trials.
Heart failure of class IV NYHA has a very severe prognosis. Its most frequent electrolytic alterations are hyponatremia, hypokalemia, and hypomagnesemia which can cause serious arrhythmias and sudden death. The regulation of the electrolytic equilibrium by means of pharmacological therapy becomes impossible in patients with severe heart failure resistant to strong doses of diuretics in the oligo-anuric phase. This study focused on the use of daily hemofiltration in a group of patients suffering from cardiac insufficiency of class IV NYHA. The results have been evaluated over 1 year.
No takes yet. Share an insight, caveat, or question.
Iorio et al. (1999) conducted an observational in Severe heart failure (class IV NYHA). Daily hemofiltration was evaluated. Daily hemofiltration was evaluated over 1 year in patients with severe class IV NYHA heart failure, but no quantitative results were reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: